FDA Import Refusal 1FX-2303588-5/10002/4 — SUN PHARMACEUTICALS IND LTD
The FDA refused shipment 1FX-2303588-5/10002/4 from SUN PHARMACEUTICALS IND LTD (India) on Sep 18, 2026. The refused product falls under Drugs and Biologics — EMPAGLIFLOZIN (ANTI-DIABETIC). Cited charge: 75
Refusal Details
- Date
- Sep 18, 2026
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 61PDA73 EMPAGLIFLOZIN (ANTI-DIABETIC)
- Charges
- 75